skip to main content
Idioma:
Resultados 1 2 3 4 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: NUS Single-Journal Subscriptions remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC

Sekulic, Aleksandar, MD ; Migden, Michael R., MD ; Lewis, Karl, MD ; Hainsworth, John D., MD ; Solomon, James A., MD, PhD ; Yoo, Simon, MD ; Arron, Sarah T., MD, PhD ; Friedlander, Philip A., MD, PhD ; Marmur, Ellen, MD ; Rudin, Charles M., MD, PhD ; Chang, Anne Lynn S., MD ; Dirix, Luc, MD, PhD ; Hou, Jeannie, MD ; Yue, Huibin, PhD ; Hauschild, Axel, MD

Journal of the American Academy of Dermatology, 2015-06, Vol.72 (6), p.1021-1026.e8 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma

Dummer, Reinhard, MD ; Guminski, Alexander, MD, PhD ; Gutzmer, Ralf, MD ; Dirix, Luc, MD ; Lewis, Karl D., MD ; Combemale, Patrick, MD ; Herd, Robert M., MD ; Kaatz, Martin, MD ; Loquai, Carmen, MD ; Stratigos, Alexander J., MD ; Schulze, Hans-Joachim, MD ; Plummer, Ruth, MD ; Gogov, Sven, MD ; Pallaud, Celine, PhD ; Yi, Tingting, PhD ; Mone, Manisha, PhD ; Chang, Anne Lynn S., MD ; Cornélis, Frank, MD ; Kudchadkar, Ragini, MD ; Trefzer, Uwe, MD ; Lear, John T., MD ; Sellami, Dalila, MD ; Migden, Michael R., MD

Journal of the American Academy of Dermatology, 2016-07, Vol.75 (1), p.113-125.e5 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial
Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial

Fosko, Scott W. ; Chu, Melinda B. ; Armbrecht, Eric ; Galperin, Tim ; Potts, Geoffrey A. ; Mattox, Adam ; Kurta, Anastasia ; Polito, Kristen ; Slutsky, Jordan B. ; Burkemper, Nicole M. ; Hurley, M. Yadira

Journal of the American Academy of Dermatology, 2020-04, Vol.82 (4), p.946-954 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma

Sofen, Howard, MD ; Gross, Kenneth G., MD ; Goldberg, Leonard H., MD, FRCP ; Sharata, Harry, MD, PhD ; Hamilton, Tiffani K., MD ; Egbert, Barbara, MD ; Lyons, Benjamin, PhD ; Hou, Jeannie, MD ; Caro, Ivor, MD

Journal of the American Academy of Dermatology, 2015-07, Vol.73 (1), p.99-105.e1 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Hedgehog pathway blockade with the cancer drug LDE225 disrupts taste organs and taste sensation
Hedgehog pathway blockade with the cancer drug LDE225 disrupts taste organs and taste sensation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hedgehog pathway blockade with the cancer drug LDE225 disrupts taste organs and taste sensation

Kumari, Archana ; Ermilov, Alexandre N ; Allen, Benjamin L ; Bradley, Robert M ; Dlugosz, Andrzej A ; Mistretta, Charlotte M

Journal of neurophysiology, 2015-02, Vol.113 (3), p.1034-1040 [Periódico revisado por pares]

United States: American Physiological Society

Texto completo disponível

Citações Citado por
6
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study

Hansson, Johan ; Bartley, Karen ; Karagiannis, Thomas ; Grob, Jean-Jacques ; Kunstfeld, Rainer ; Dréno, Brigitte ; Mortier, Laurent ; Ascierto, Paolo A. ; Licitra, Lisa ; Dutriaux, Caroline ; Thomas, Luc ; Meyer, Nicolas ; Guillot, Bernard ; Dummer, Reinhard ; Fife, Kate ; Ernst, D. Scott ; Yim, Yeun Mi ; Dimier, Natalie ; Fittipaldo, Alberto ; Basset-Séguin, Nicole ; Hauschild, Axel

EJD. European journal of dermatology, 2018-12, Vol.28 (6), p.775-783 [Periódico revisado por pares]

Paris: John Libbey Eurotext

Texto completo disponível

Citações Citado por
7
The importance of caregivers for patients with advanced basal cell carcinoma treated with hedgehog-pathway inhibitors: an observational prospective study
The importance of caregivers for patients with advanced basal cell carcinoma treated with hedgehog-pathway inhibitors: an observational prospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

The importance of caregivers for patients with advanced basal cell carcinoma treated with hedgehog-pathway inhibitors: an observational prospective study

Trane, Luciana ; Salvati, Lorenzo ; Silvestri, Flavia ; Venturi, Federico ; Zuccaro, Biancamaria ; Perillo, Gabriella ; De Giorgi, Vincenzo

EJD. European journal of dermatology, 2024-02, Vol.34 (1), p.68-72 [Periódico revisado por pares]

France

Texto completo disponível

Citações Citado por
8
The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma
The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma

Collier, Nicholas J ; Ali, Faisal R ; Lear, John T

2016-10

Texto completo disponível

Citações Citado por
9
The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma
The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma

Collier, Nicholas J. ; Ali, Faisal R. ; Lear, John T.

Expert review of anticancer therapy, 2016-10, Vol.16 (10), p.1011-1018 [Periódico revisado por pares]

England: Taylor & Francis

Sem texto completo

Citações Citado por
10
Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways
Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways

Macdonald, James B ; Macdonald, Brooke ; Golitz, Loren E ; LoRusso, Patricia ; Sekulic, Aleksandar

Journal of the American Academy of Dermatology, 2015-02, Vol.72 (2), p.221 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (35)
  2. Revistas revisadas por pares (35)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (37)
  2. Anais de Congresso  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2011  (3)
  2. 2011Até2013  (5)
  3. 2014Até2016  (19)
  4. 2017Até2020  (10)
  5. Após 2020  (2)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.